SBIR/STTR Research Award

Development of a commercial assay for the rapid and general detection of PFAS in environmental matrices (Phase I)

Award identifier 75b4c1c5f165eabb851e3c74dd3823b2941f5dcb40262d9153e0e34c9017f8c2Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$167,999

Program and phase

SBIR · Phase I

Award year

2021

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
WEAVER LABS LLC
Proposal award date
2021-04-01
Contract end date
2022-09-30
UEI
ENWMQ5VRY2S5
Solicitation number
PA19-272
Topic code
R

Research abstract

AbstractPolyfluoro- and perfluoroalkyl substances (PFAS) are a group of highly fluorinated alkanes. Members of this family are known to be persistent and bioaccumulative. PFAS are associated with unfavorable health outcomes in human and animal models. Several public health agencies as well as scientists have published articles that indicate the presence of PFAS in human blood, serum, milk, cord blood, and tissues. Currently, detection of about a dozen of these chemicals out of more than a thousand of this class is performed using LCMS/MS. However, prior to analysis many purification steps are required to eliminate interfering species. Furthermore, the necessity of internal standards for the detection of PFAS, and the lack of pertinent internal standards dramatically reduces the scope of PFAS-detection. Currently, PFAS testing is a lengthy and costly undertaking that represents a major scientific bottleneck. Thus, there is an urgent need for a real-time detection technology that can sense a broad range of PFAS without pretreatment of sample, or expensive instrumentation. Implementation of such a product will allow better understanding of the fate of PFAS within the environment and their impact on human health.This proposal’s objective is to develop the pre-treatment free detection of PFAS in environmental matrices by coupling the key fluorous phase property with a highly sensitive fluorescence technology. In phase 1, we will apply the specific fluorous-fluorous interaction strategy to provide the adequate selectivity to preclude any associated purification steps. Fluorous tethered fluorescent dyes will be covalently immobilized on a glass surface. Initially, prior to exposure to PFAS, these fluorescent dyes will exist as excimers resulting from their close proximity to each other, the fluorescent probe turns the fluorescence on. Upon exposure to PFAS analytes, the analytes will be sequestered to the fluorous region of the probe due to specific fluorous-fluorous affinity. This will cause a physical disruption of the excimers, resulting in the fluorescence turn off of the excimer and a simultaneous turn on of the monomer emission. To achieve the proposed goal, in phase I the following specific aims will be pursued: specific aim1: 1) attachment of the fluorescent dye to the fluorous molecule, 2) immobilization of fluorous-dye array on glass surface, and 3) evaluation of fluorescence on-off of fluorous-dye glass surface with PFAS-samples. Ultimately the approach developed here will lay the groundwork for the development of a product that is expected to enable a broad range of researchers to study many types of effects on human health caused by PFAS.Project Narrative Rapid detection and quantification of PFAS is an immediate need for better understanding their properties such as their partition in different environmental matrices, health risks, exposure routes, fate and transportation, etc. In order to drive advancement of such study a novel approach will be applied for generation of chip-based PFAS sensors that can rapidly detect and quantify a broad range of PFAS in environmental matrices such as ground water, surface water, soil, etc. This technique is eventually expected to lead to a portable device that can enable the generation of bountiful information that will facilitate regulatory decision making, monitoring of PFAS sources, and ultimately reducing future exposures that benefit society.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

5 SBIR/STTR records share this UEI (2019–2023). Reported award amounts total $621,479. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services, Department of Defense, Department of Agriculture

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.